Research ArticleGenes Encoding Enzymes Responsible for Biosynthesis of L-Lyxose and Attachment of Eurekanate during Avilamycin (cas 11051-71-1) Biosynthesis
-
Add time:08/21/2019 Source:sciencedirect.com
SummaryThe oligosaccharide antibiotic Avilamycin (cas 11051-71-1) A is composed of a polyketide-derived dichloroisoeverninic acid moiety attached to a heptasaccharide chain consisting of six hexoses and one unusual pentose moiety. We describe the generation of mutant strains of the avilamycin producer defective in different sugar biosynthetic genes. Inactivation of two genes (aviD and aviE2) resulted in the breakdown of the avilamycin biosynthesis. In contrast, avilamycin production was not influenced in an aviP mutant. Inactivation of aviGT4 resulted in a mutant that accumulated a novel avilamycin derivative lacking the terminal eurekanate residue. Finally, AviE2 was expressed in Escherichia coli and the gene product was characterized biochemically. AviE2 was shown to convert UDP-D-glucuronic acid to UDP-D-xylose, indicating that the pentose residue of avilamycin A is derived from D-glucose and not from D-ribose. Here we report a UDP-D-glucuronic acid decarboxylase in actinomycetes.
We also recommend Trading Suppliers and Manufacturers of Avilamycin (cas 11051-71-1). Pls Click Website Link as below: cas 11051-71-1 suppliers
Prev:Research PaperBiosynthesis of the orthosomycin antibiotic Avilamycin (cas 11051-71-1) A: deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics
Next:Effects on skin of Stichopus japonicus viscera extracts detected with saponin including Holothurin A: Down-regulation of melanin synthesis and up-regulation of neocollagenesis mediated by ERK signaling pathway) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research PaperBiosynthesis of the orthosomycin antibiotic Avilamycin (cas 11051-71-1) A: deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics08/20/2019
- Short communicationDetermination of Avilamycin (cas 11051-71-1) A and B in pig faeces by solid phase extraction and reverse-phase HPLC assay08/19/2019
- ArticleNovel Avilamycin (cas 11051-71-1) Derivatives with Improved Polarity Generated by Targeted Gene Disruption08/18/2019
- Use of Avilamycin (cas 11051-71-1) for growth promotion and Avilamycin (cas 11051-71-1)-resistance among Enterococcus faecium from broilers in a matched case–control study in France08/17/2019
- Analytical MethodsDetermination of total Avilamycin (cas 11051-71-1) residues as dichloroisoeverninic acid in porcine muscle, fat, and liver by LC-MS/MS08/16/2019